OAKES FRANK R. 4
4 · Edesa Biotech, Inc. · Filed Mar 7, 2022
Insider Transaction Report
Form 4
OAKES FRANK R.
DirectorPresident, CEO & Director
Transactions
- Award
Stock Option (right to buy)
2022-02-28+11,000→ 11,000 totalExercise: $3.71Exp: 2022-02-28→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]This option vests monthly in equal proportions over 12 months beginning on the Grant Date.